426 related articles for article (PubMed ID: 20361906)
1. Does the therapy manual or the therapist matter most in treatment of obsessive-compulsive disorder? A randomized controlled trial of exposure with response or ritual prevention in 118 patients.
van Oppen P; van Balkom AJ; Smit JH; Schuurmans J; van Dyck R; Emmelkamp PM
J Clin Psychiatry; 2010 Sep; 71(9):1158-67. PubMed ID: 20361906
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of self-directed versus therapist-directed cognitive-behavioral therapy for obsessive-compulsive disorder patients with prior medication trials.
Tolin DF; Hannan S; Maltby N; Diefenbach GJ; Worhunsky P; Brady RE
Behav Ther; 2007 Jun; 38(2):179-91. PubMed ID: 17499084
[TBL] [Abstract][Full Text] [Related]
3. Psychological treatment of obsessive-compulsive disorder: a meta-analysis.
Rosa-Alcázar AI; Sánchez-Meca J; Gómez-Conesa A; Marín-Martínez F
Clin Psychol Rev; 2008 Dec; 28(8):1310-25. PubMed ID: 18701199
[TBL] [Abstract][Full Text] [Related]
4. Cognitive versus behavior therapy: processes of change in the treatment of obsessive-compulsive disorder.
Anholt GE; Kempe P; de Haan E; van Oppen P; Cath DC; Smit JH; van Balkom AJ
Psychother Psychosom; 2008; 77(1):38-42. PubMed ID: 18087206
[TBL] [Abstract][Full Text] [Related]
5. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
[TBL] [Abstract][Full Text] [Related]
6. Manual-Driven group cognitive-behavioral therapy for adolescents with obsessive-compulsive disorder: a pilot study.
Thienemann M; Martin J; Cregger B; Thompson HB; Dyer-Friedman J
J Am Acad Child Adolesc Psychiatry; 2001 Nov; 40(11):1254-60. PubMed ID: 11699798
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of teaching psychology students exposure and response prevention for obsessive-compulsive disorder.
Solem S; Hansen B; Vogel PA; Ottesen Kennair LE
Scand J Psychol; 2009 Jun; 50(3):245-50. PubMed ID: 19170968
[TBL] [Abstract][Full Text] [Related]
8. Predicting therapy outcome in patients with early and late obsessive-compulsive disorder (EOCD and LOCD).
Langner J; Laws M; Röper G; Zaudig M; Hauke W; Piesbergen C
Behav Cogn Psychother; 2009 Oct; 37(5):485-96. PubMed ID: 19796435
[TBL] [Abstract][Full Text] [Related]
9. Behavioural group therapy for obsessive-compulsive disorder in Norway. An open community-based trial.
Håland AT; Vogel PA; Lie B; Launes G; Pripp AH; Himle JA
Behav Res Ther; 2010 Jun; 48(6):547-54. PubMed ID: 20359692
[TBL] [Abstract][Full Text] [Related]
10. Defining treatment response and remission in obsessive-compulsive disorder: a signal detection analysis of the Children's Yale-Brown Obsessive Compulsive Scale.
Storch EA; Lewin AB; De Nadai AS; Murphy TK
J Am Acad Child Adolesc Psychiatry; 2010 Jul; 49(7):708-17. PubMed ID: 20610140
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.
Wilhelm S; Buhlmann U; Tolin DF; Meunier SA; Pearlson GD; Reese HE; Cannistraro P; Jenike MA; Rauch SL
Am J Psychiatry; 2008 Mar; 165(3):335-41; quiz 409. PubMed ID: 18245177
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples.
Franklin ME; Abramowitz JS; Kozak MJ; Levitt JT; Foa EB
J Consult Clin Psychol; 2000 Aug; 68(4):594-602. PubMed ID: 10965635
[TBL] [Abstract][Full Text] [Related]
13. Need for speed: evaluating slopes of OCD recovery in behavior therapy enhanced with d-cycloserine.
Chasson GS; Buhlmann U; Tolin DF; Rao SR; Reese HE; Rowley T; Welsh KS; Wilhelm S
Behav Res Ther; 2010 Jul; 48(7):675-9. PubMed ID: 20362975
[TBL] [Abstract][Full Text] [Related]
14. Effect of D-Cycloserine on the Effect of Concentrated Exposure and Response Prevention in Difficult-to-Treat Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
Kvale G; Hansen B; Hagen K; Abramowitz JS; Børtveit T; Craske MG; Franklin ME; Haseth S; Himle JA; Hystad S; Kristensen UB; Launes G; Lund A; Solem S; Öst LG
JAMA Netw Open; 2020 Aug; 3(8):e2013249. PubMed ID: 32789516
[TBL] [Abstract][Full Text] [Related]
15. Serious negative consequences associated with exposure and response prevention for obsessive-compulsive disorder: A survey of therapist attitudes and experiences.
Schneider SC; Knott L; Cepeda SL; Hana LM; McIngvale E; Goodman WK; Storch EA
Depress Anxiety; 2020 May; 37(5):418-428. PubMed ID: 32048376
[TBL] [Abstract][Full Text] [Related]
16. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.
Farrell LJ; Waters AM; Boschen MJ; Hattingh L; McConnell H; Milliner EL; Collings N; Zimmer-Gembeck M; Shelton D; Ollendick TH; Testa C; Storch EA
Depress Anxiety; 2013 Aug; 30(8):723-31. PubMed ID: 23722990
[TBL] [Abstract][Full Text] [Related]
17. How effective are cognitive and behavioral treatments for obsessive-compulsive disorder? A clinical significance analysis.
Fisher PL; Wells A
Behav Res Ther; 2005 Dec; 43(12):1543-58. PubMed ID: 16239151
[TBL] [Abstract][Full Text] [Related]
18. Treatment of monozygotic twins with obsessive compulsive disorder using cognitive therapy and exposure with ritual prevention.
Twohig MP; Whittal ML; Peterson KA
Behav Cogn Psychother; 2009 Jul; 37(4):475-80. PubMed ID: 19563690
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of exposure with response-prevention for obsessive compulsive disorder in childhood and adolescence.
Bolton D; Perrin S
J Behav Ther Exp Psychiatry; 2008 Mar; 39(1):11-22. PubMed ID: 17207457
[TBL] [Abstract][Full Text] [Related]
20. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
Foa EB; Liebowitz MR; Kozak MJ; Davies S; Campeas R; Franklin ME; Huppert JD; Kjernisted K; Rowan V; Schmidt AB; Simpson HB; Tu X
Am J Psychiatry; 2005 Jan; 162(1):151-61. PubMed ID: 15625214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
